Increased serum and cerebrospinal fluid (CSF) levels of C5a and the soluble terminal complement complex C5b-C9 have also been documented in patients with CIDP [11]. Here, C5AR1 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.